최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓本草學會誌 = The Korea journal of herbology, v.26 no.3, 2011년, pp.65 - 73
이인우 (대구한의대학교 한의학과 간계내과학교실) , 최홍식 (대구한의대학교 한의학과 간계내과학교실) , 김승모 (대구한의대학교 한의학과 간계내과학교실)
Objectives : The present study was evaluated the protective roles of Spatholobi Caulis in hepatotoxic rats due to APAP overdose. Methods : In experiments, rats were orally administrated with the aqueous extract of Spatholobi Caulis (SCE; 50, 100 mg/kg) for 4 days and then, orally gavage with APAP (1...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
Acetaminophen (APAP) 단회 투여로 급성 간독성을 유발한 rat에 대한 계혈등 물추출물 (SCE)의 간보호 효과를 평가한 결과는? | 그 결과 SCE는 APAP에 의해 증가된 ALT, AST, LDH 수치 및 간 조직의 변성율, 침윤된 염증세포의 수 및 변성 간세포수, hepatic MDA 함량을 유의하게 감소시켰으며, 또한 APAP에 의해 감소된 Hepatic glutathione (GSH)를 유의하게 증가시켰다. 이러한 결과로 보아 계혈등은 APAP로 유도된 급성 간독성에 대해 유의한 보호 효과를 나타내었으며, 특히 GSH의 감소를 억제하고 지질과산화를 막음으로써 간보호 효과를 나타낸 것으로 보여 진다. | |
鷄血藤이란? | 鷄血藤 (Spatholobi Caulis)은 콩과 (Leguminosae) 밀화두 (Spatholobus suberectus Dunn)의 덩굴줄기로 補血活血 효과가 있어 瘀血, 月經不順, 貧血의 치료에 사용되고 있으며1,2), 최근의 연구에서는 염증억제 효과3), 항산화 효과4), 항노화 작용5), 뇌혈류개선 작용6,7), 세포주기 억제 및 세포사멸유도 작용8,9), 지질대사조절 작용10), 면역조절 작용11) 및 관절염 억제12,13) 등의 다양한 약리 작용을 가지는 것으로 보고되고 있다. 계혈등의 구성화합물로는 formononectin, daidzein, isoliquiritigenein, sativan, stigmasterol, campesterol, medicagol, psudobaptigenin 등의 flavonoid 및 sterol 계열 화합물이 등이 알려져 있다14,15). | |
鷄血藤은 최근 연구에서 어떠한 약리 작용을 가지는 것으로 보고되고 있는가? | 鷄血藤 (Spatholobi Caulis)은 콩과 (Leguminosae) 밀화두 (Spatholobus suberectus Dunn)의 덩굴줄기로 補血活血 효과가 있어 瘀血, 月經不順, 貧血의 치료에 사용되고 있으며1,2), 최근의 연구에서는 염증억제 효과3), 항산화 효과4), 항노화 작용5), 뇌혈류개선 작용6,7), 세포주기 억제 및 세포사멸유도 작용8,9), 지질대사조절 작용10), 면역조절 작용11) 및 관절염 억제12,13) 등의 다양한 약리 작용을 가지는 것으로 보고되고 있다. 계혈등의 구성화합물로는 formononectin, daidzein, isoliquiritigenein, sativan, stigmasterol, campesterol, medicagol, psudobaptigenin 등의 flavonoid 및 sterol 계열 화합물이 등이 알려져 있다14,15). |
Colleges of Oriental Medicine. Herbology professor's association. Herbology. Seoul:Young-Lim Publisher. 1992:445-6.
Hu-Zhan Zheng(鄭虎占). Modern study of traditional chinese medicine(中藥現代硏究與應用). Beijing:xue-yuan Publisher(學苑出版社). 1998:2539-46.
Choi SI, Park SJ, Byun SH, Lee JR, Park MK, Kim SC. Effects of Spatholobi Caulis MeOH Extract on the Production of NO and Pro-inflammatory Cytokines in LPS-activated Raw264.7 Cells. Korean J. Herbology. 2009;24(2):21-7.
Cha BC, Lee EH, Noh MA. Antioxidant Activity of Spatholobus suberectus Dunn. Kor. J. Phamacogn. 2005;36(1):50-5.
Lee SL, Jeong HW. Experimental Effects of SPATHOLOBI CAULIS on the Cerebral Blood Flow and Lactate Dehydrogenase Activity. Korean J. Oriental Phyology & Pathology. 2006;20(1):25-30.
Lee SL, Choi CH, Baek JU, Youn DH, Jeong SH, Han U, et al. Experimental Study of Patholobi Caulis on the Transient Cerebral Ischemia in Rats. Korean J. Oriental Phyology & Pathology. 2007;21(5):1127-34.
Kim DC, Ramachandran S, Baek SH, Kwon SH, Kwon KY, Cha SD, Bae I, Cho CH. Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod Sci. 2008;15/6:552-558.
Ha ES, Lee EO, Yoon TJ, Kim JH, Park JO, Lim NC, Jung SK, Yoon BS, Kim SH. Methylene chloride fraction of Spatholobi Caulis induces apoptosis via caspase dependent pathway in U937 cells. Biol Pharm Bull. 2004;27(9):1348-52.
Wang W, Wang J, Zhao D, Liu H, Zhou W, Chen K. Comparison of Spatholobus suberectus Dunn Euonymus alatus (Thunb.) Sied. and Eupolyphage sinensis Walkeron regulation of plasma lipid. Zhongguo Zhong Yao Za Zhi. 1991;16:299-301, 320.
Lam TL, Lam ML, Au TK, Ip DT, Ng TB, Fong WP, Wan DC. A comparison of human imminodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs, Life Sci. 2000;67(23):2889-96.
Choi JS, Song TW, Kim DH. A Study on the effect Spatholobus suberectus Dunn on the inhibition of arthritis by collagen on the mouse, Kor. J. Herbology. 2003;18:79-88.
So HG, Oh MS, Kim DH. Immunity Responses of the Spatholobus suberectus Dunn to Synovial Cells Isolated from Patients with Rheumatoid Arthritis, Korean. J. Oriental Phtsiol Pathol. 2003;17:780-6.
Yoon-JS. Flavonoids of spatholobus suberectus [master's thesis]. Seoul:Graduate school, Seoul University:2003.
Zhu You Ping. Chinese materia medica. Harwood academic publisher. The Netherlands. 1998:468-470.
Farrell S. Toxicity, acetaminophen. eMedicine Journal 2009;(September):3.
Ruepp S, Tonge R, Shaw J, Wallis N, Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicological Sciences. 2002;65:135-50.
Larson A, Polson J, Fontana R, Davern T, Lalani E, Hynan L, et al. Acetaminophen-induced acute liver failure:results of a United States multicenter, prospective study. Hepatology. 2005;42:1364-72.
Knight T, Fariss M, Farhood A, Jaeschke H. Role of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in mice. Toxicological Sciences. 2003;76:229-36.
Goldfrank L, Flomenbaum N. Goldfrank's toxicologic emergencies: McGRAW-Hill Professional;2006.
Nelson SD. Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab Rev. 1995;27:147-77.
Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis. 2007;11:459-75,
Hao Y, Linling C, Michael H, Numsen H Jr, Robert M. Cynthia J. Lactoferrin protects against acetaminophen-induced liver injury in mice. Hepatology. 2010;51:1007-16.
Lee WM. Acetaminophen and the US Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004;40:6-9.
Fischer LJ, Green MD, Harman AW. Levels of acetaminophen and its metabolites in mouse tissue after a toxic dose. J Pharmacol EXP Ther 1986;219:281-286
Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci. 2006;9:31-41.
James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos. 2003;31(12):1499-506.
Michael SL. Pumford NR. Mayeux PR. Niesman MR. Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology. 1999;30:186-95.
Hinson JA. Reid AB. McCullough SS. James LP. Acetaminophen induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metabolism Reviews. 2004;36:805-22.
Hinson JA. Bucci AR. Irwin LK. Michael SL Mayeux PR, Effect of inhibitors of nitric oxide synthase on acetaminophen-induced hepatotoxicity in mice. Nitric Oxide. 2002;6:160-7.
Bergman K. Muller L. Teigen SW. Series: The genotoxicity and carcinogenicity of paracetamol: a regulatory review. Mutation Research. 1996;349:263-88.
Dybing E. Holme JA. Gordon WP. Soderlund EJ. Dahlin DC. Nelson SD. Genotoxicity studies with paracetamol. Mutation Research. 1984;138:21-32.
Ismail NA, Okasha SH, Dhawan A, Abdel-Rahman AO, Shaker OG, Sadik NA. Antioxidant enzyme activities in hepatic tissue from children with chronic cholestatic liver disease. Saudi J Gastroenterol. 2010;6(2):90-4.
Dhaunsi GS, Singh I, Orak JK, Singh AK. Antioxidant enzymes in ciprofibrate-induced oxidative stress. Carcinogenesis. 1994;15(9):1923-30.
Olaleye MT, Akinmoladun AC, Ogunboye AA, Akindahunsi AA. Antioxidant activity and hepatoprotective property of leaf extracts of Boerhaavia diffusa Linn against acetaminophen -induced liver damage in rats Food Chem Toxicol. 2010;48(8-9):2200-5.
Das J, Ghosh J, Manna P, Sil PC. Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1. Free Radic Res. 2010;44(3):340-55.
Zaher H, Buters JT, Ward JM, Bruno MK, Lucas AM, Stern ST, Cohen SD, Gonzalez FJ. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol. 1998;152(1):193-9.
Prescott LF. Paracetamol: past, present, and future. Am J Ther 2000;7:143-7
Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJM, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure:a prospective controlled trial. BMJ 1991;303:1026-9
Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity(1987-1993). Gastroenterology 1995;109:1907-16
Yang R, Miki K, He X, Killeen ME, Fink MP. Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity. Crit Care. 2009;13:R55.
Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity:predisposing factors and treatments. Adv Intern Med. 1997;42:453-83
Ahn BM. Acetaminophen-Induced Acute Liver Failure J Korean Med Assoc. 2006;49(9):846-53
Dudley RE, Svoboda DJ, Klaassen C. Acute exposure to cadmium causes severe liver injury in rats, Toxicol. Appl. Pharmacol. 1982;65:302-13.
Skilleter D, Cain K, Dinsdale D, Paine A. Biochemical mechanisms and morphology selectivity in hepatotoxicity: Studies in cultures of hepatic-parenchymal and non-parenchymal cells. Xenobiotica. 1985;15:687-93.
Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease:implications for epidemiologic studies. Gastroenterology. 2003;24:248-50.
Scheig R. Evaluation of tests used to screen patients with liver disorders. Prim Care. 1996;23:551-60.
Sherlock S, Dooley J. Diseases of liver and biliary system. London:Blackwell Science. 2002:23.
Fisher LJ.Green MD. Harman AW. Levels of acetaminophen and it's metabolites in mouse tissues after a toxic dose. J Pharmacol Exp Therapeut. 1982;221:407-13.
Muller L. Consequences of cadmium toxicity in rat hepatocytes:mitochondrial dysfunction and lipid peroxidation. Toxicology. 1986;40:285-92.
Manca D. Ricard AC. Trottier B. Chevalier G. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology. 1991;67:303-23.
Bray TM. Taylor CG. Tissue glutathione, nutrition and oxidative stress. Can. J. Physiol. Pharmacol. 1993;71:746-75.
Han D, Shinohara M, Ybanez MD, Saberi B, Kaplowitz N. Signal transduction pathways involved in drug-induced liver injury. Handb Exp Pharmacol. 2010;196:267-310.
Yuan L, Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009;30(1-2):29-41.
Dahlin, DC, Miwa GT, Lu AYH, Nelson SD. N-acetyl-p-benzoquinone imine:a cytochrome P-450 mediated oxidation product of acetaminophen. Biochemistry. 1984;81:1327-331.
Ferret PJ, Hammoud R, Tulliez M, Tran A., Trebeden H, Jaffray P, Malassagne B, Calmus Y, Weill B, Batteux F. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminopheninduced acute liver failure in the mouse. Hepatology. 2001;33:1173-80.
Kanno S, Ishikawsa M, Takayanagi M, Takayanagi Y, Sasaki K. Potentiation of acetaminophen hepatotoxicity by doxapram in mouse primary cultured hepatocytes. Biol. Pharm. Bull. 2000;23:446-550.
Ray SD, Mumaw VR, Raje RR, Fariss MW. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J. Pharmacol. Exp. Ther. 1996;279:1470-83.
Ray SD, Jena NA. hepatotoxic dose of acetaminophen modulates expression of BCL-2, BCL-X(L), and BCL-X(S) during apoptotic and necrotic death of mouse liver cells in vivo. Arch. Toxicol. 2000;73:594-606.
Zhang H, Cook J, Nickel J, Yu R, Stecker K, Myers K, Dean NM. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat. Biotechnol. 2000;18:862-67.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.